Charles Tam is a medical device industry professional with nearly 15 years of progressive leadership across regulatory affairs, compliance, and quality in Canada. He is the Director of Regulatory Affairs, Intelligence and Governance at the Canadian head-office of Edwards Lifesciences Inc., a global leader in patient-focused medical innovations for structural heart disease, as well as critical care and surgical monitoring.

Charles brings a robust cardiovascular medical device specialization in Special Access, Investigational Testing, and high-risk Class IV combination drug & biological tissue implants. Additionally, he also leads the emerging business focus areas of Regulatory Intelligence and Regulatory Governance for both Canada and the international markets (Europe, Middle East, Africa, Latin America, and emerging markets). He previously held progressive regulatory roles at Becton-Dickinson, Johnson & Johnson, and Abbott Laboratories. He holds a B.Sc (Honours) from the University of Toronto and a MBA from Ryerson University in Canada.